Device
Therapeutic Plasma Exchange (TPE)
Therapeutic Plasma Exchange (TPE) is a medical device with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
1(17%)
Results Posted
33%(1 trials)
Phase Distribution
Ph early_phase_1
1
17%
Ph phase_4
1
17%
Ph not_applicable
3
50%
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
3(60.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
6
all time
Status Distribution
Active(1)
Completed(3)
Other(2)
Detailed Status
Completed3
unknown2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Early Phase 11 (20.0%)
Phase 41 (20.0%)
N/A3 (60.0%)
Trials by Status
recruiting117%
completed350%
unknown233%
Recent Activity
1 active trials
Showing 5 of 6
recruitingnot_applicable
Efficacy of Add-on Plasma Exchange As an Adjunctive Strategy Against Septic Shock
NCT05726825
completed
TPE in Rennes Hospital
NCT03888417
completedphase_4
Therapeutic Plasma Exchange for COVID-19-associated Hyperviscosity
NCT04441996
unknownearly_phase_1
Plasmapheresis for Treatment of Age-Related Frailty
NCT05054894
completednot_applicable
Therapeutic Plasma Exchange in Resistant Cytokine Storm of COVID 19
NCT04457349
Clinical Trials (6)
Showing 6 of 6 trials
NCT05726825Not Applicable
Efficacy of Add-on Plasma Exchange As an Adjunctive Strategy Against Septic Shock
NCT03888417
TPE in Rennes Hospital
NCT04441996Phase 4
Therapeutic Plasma Exchange for COVID-19-associated Hyperviscosity
NCT05054894Early Phase 1
Plasmapheresis for Treatment of Age-Related Frailty
NCT04457349Not Applicable
Therapeutic Plasma Exchange in Resistant Cytokine Storm of COVID 19
NCT02906345Not Applicable
TPE in Septic Patients and Influence on Organ Failure
All 6 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 6